Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Edwards Lifesciences; Boston Scientific Corporation; Medtronic; Abbott; 4C Medical; Siemens Healthineers
• Equity/Stock(s)/Options - Mycardium AI
• Consultant Fee/Honoraria/Speaker's Bureau - JenaValve; JC Medical